EUVIMEDEUVIMED entdecken
Open Access

Enhancer RNA–mediated transcriptional regulatory programs reveal the malignant progression of glioma

Yingying Ma iD, Shuyuan Wang iD, Yijie Jia iD, Shijie Wang, Wendian Liu iD, Jiaxin Yu iD, Jun Wang, Jingkai Geng iD, Jiayi Zhao iD, Zheng Zhao iD, Juan Xu iD, Hui Liu iD

Science Advances · 06.06.2025 · 11 (23)

DOI: 10.1126/sciadv.adu9487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 06.06.2025. Verfasst von Yingying Ma und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, Heilongjiang Province, China. Hauptthemen laut MEDLINE: Glioma, Enhancer RNAs. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To systematically investigate the molecular and pathological mechanisms of enhancer RNA (eRNA)–mediated transcriptional regulation in glioma recurrence and progression, transcriptomic, regulatome, and genomic data were integrated to analyze eRNA behavior in lower-grade gliomas (stages II/III) and glioblastomas (stage IV). Most eRNAs exhibited dynamic expression during glioma progression, regulated by master transcription factors (TFs) and affected by genomic mutations. The constructed perturbed TF-mediated eRNA-promoter regulatory landscape revealed that rewiring eRNA-promoter networks contributed to glioma malignancy. Drug response–related eRNAs associated with poor prognosis were identified, highlighting their clinical potential. Overall, integrative analysis highlights the critical role of eRNA-mediated regulatory rewiring in glioma progression, providing valuable insights into transcriptional mechanisms and potential therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaEnhancer RNAsGene Expression Regulation, NeoplasticTranscription FactorsMutationPromoter Regions, GeneticDisease ProgressionHumansCell Line, Tumor

Substanzen

Enhancer RNAsTranscription Factors

Autor:innen und Institutionen

  • College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, Heilongjiang Province, China.
  • State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Harbin Medical University, Harbin 150076, China.
  • Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China.

ORCID-Profile: Yingying Ma, Shuyuan Wang, Yijie Jia, Wendian Liu, Jiaxin Yu, Jingkai Geng, Jiayi Zhao, Zheng Zhao, Juan Xu, Hui Liu

Zitieren

APA

Ma, Y., Wang, S., Jia, Y., Wang, S., Liu, W., Yu, J., Wang, J., Geng, J., Zhao, J., Zhao, Z., Xu, J., & Liu, H. (2025). Enhancer RNA–mediated transcriptional regulatory programs reveal the malignant progression of glioma. Science Advances, 11(23). https://doi.org/10.1126/sciadv.adu9487

Vancouver

Ma Y, Wang S, Jia Y, Wang S, Liu W, Yu J, et al. Enhancer RNA–mediated transcriptional regulatory programs reveal the malignant progression of glioma. Science Advances. 2025;11(23). doi:10.1126/sciadv.adu9487

BibTeX
@article{Ma2025,
  author = {Ma, Yingying and Wang, Shuyuan and Jia, Yijie and Wang, Shijie and Liu, Wendian and Yu, Jiaxin and Wang, Jun and Geng, Jingkai and Zhao, Jiayi and Zhao, Zheng and Xu, Juan and Liu, Hui},
  title = {Enhancer RNA–mediated transcriptional regulatory programs reveal the malignant progression of glioma},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {23},
  doi = {10.1126/sciadv.adu9487}
}
Kostenlos starten →